Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates

le Kudgus, Rachel A., Bhattacharya, Resham, Mukherjee, Priyabrata
Foilsithe in Anticancer Agents Med Chem (2011)

Inorganic Nanoparticles in Cancer Therapy

le Bhattacharyya, Sanjib, Kudgus, Rachel A., Bhattacharya, Resham, Mukherjee, Priyabrata
Foilsithe 2010

Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component

le Kudgus, Rachel A., Walden, Chad A., McGovern, Renee M., Reid, Joel M., Robertson, J. David, Mukherjee, Priyabrata
Foilsithe 2014

Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics

le Kudgus, Rachel A., Szabolcs, Annamaria, Khan, Jameel Ahmad, Walden, Chad A., Reid, Joel M., Robertson, J. David, Bhattacharya, Resham, Mukherjee, Priyabrata
Foilsithe 2013

A Phase 1 Study of the c-Met Inhibitor, Tivantinib (ARQ197) in Children with Relapsed or Refractory Solid Tumors: A Children’s Oncology Group Study Phase 1 and Pilot Consortium Tri...

le Geller, James I., Perentesis, John P., Liu, Xiaowei, Minard, Charles G., Kudgus, Rachel A., Reid, Joel M., Fox, Elizabeth, Blaney, Susan M., Weigel, Brenda J.
Foilsithe in Pediatr Blood Cancer (2017)

A Study of Axitinib (INLYTA(™)), a VEGF Receptor Tyrosine Kinase Inhibitor, in Children and Adolescents with Recurrent or Refractory Solid Tumors: A Children’s Oncology Group Phase...

le Geller, James I., Fox, Elizabeth, Turpin, Brian, Goldstein, Stuart, Liu, Xiaowei, Minard, Charles G., Kudgus, Rachel A., Reid, Joel M., Berg, Stacey, Weigel, Brenda J.
Foilsithe in Cancer (2018)

Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits

le Roy Chowdhury, Uttio, Kudgus, Rachel A., Rinkoski, Tommy A., Holman, Bradley H., Bahler, Cindy K., Hann, Cheryl R., Reid, Joel M., Dosa, Peter I., Fautsch, Michael P.
Foilsithe in PLoS One (2020)

Nivolumab in children and young adults with relapsed/refractory solid tumors (ADVL1412): A Phase 1 / 2 Trial

le Davis, Kara L., Fox, Elizabeth, Merchant, Melinda S., Reid, Joel M., Kudgus, Rachel A., Liu, Xiaowei, Minard, Charles G., Voss, Stephan, Berg, Stacey L., Weigel, Brenda J., Mackall, Crystal L.
Foilsithe in Lancet Oncol (2020)

Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo

le Khan, Jameel Ahmad, Kudgus, Rachel A., Szabolcs, Annamaria, Dutta, Shamit, Wang, Enfeng, Cao, Sheng, Curran, Geoffry L., Shah, Vijay, Curley, Steven, Mukhopadhyay, Debabrata, Robertson, J. David, Bhattacharya, Resham, Mukherjee, Priyabrata
Foilsithe 2011

A Phase 1 Study of Cabozantinib in Children and Adolescents with Recurrent or Refractory Solid Tumors, Including CNS Tumors: Trial ADVL1211, A Report from the Children’s Oncology G...

le Chuk, Meredith K., Widemann, Brigitte C., Minard, Charles G., Liu, Xiaowei, Kim, AeRang, Bernhardt, M. Brooke, Kudgus, Rachel A., Reid, Joel M., Voss, Stephan D., Blaney, Susan, Fox, Elizabeth, Weigel, Brenda J.
Foilsithe in Pediatr Blood Cancer (2018)

Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates

le Roy Chowdhury, Uttio, Kudgus, Rachel A., Holman, Bradley H., Rinkoski, Tommy A., Hann, Cheryl R., Bahler, Cindy K., McCloud, Eric, Appt, Susan E., Reid, Joel M., Dosa, Peter I., Fautsch, Michael P.
Foilsithe in J Ocul Pharmacol Ther (2021)

Phase I Clinical Trial of the Wee1 inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors. A COG Phase 1 Consortium Report (ADVL1312)

le Cole, Kristina A., Pal, Sharmistha, Kudgus, Rachel A., Ijaz, Heba, Liu, Xiaowei, Minard, Charles G., Pawel, Bruce, Maris, John M., Haas-Kogan, Daphne, Voss, Stephan, Berg, Stacey L., Reid, Joel M., Fox, Elizabeth, Weigel, Brenda J.
Foilsithe in Clin Cancer Res (2019)

ADVL1522: A Phase 2 Study of Lorvotuzumab Mertansine (IMGN901) in Children with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malig...

le Geller, James I, Pressey, Joseph G, Smith, Malcolm A, Kudgus, Rachel A, Cajaiba, Mariana, Reid, Joel M, Hall, David, Barkauskas, Donald A, Voss, Stephen D, Cho, Steve Y, Berg, Stacey L, Dome, Jeffrey S, Fox, Elizabeth, Weigel, Brenda J
Foilsithe in Cancer (2020)

Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth

le Saha, Sounik, Xiong, Xunhao, Chakraborty, Prabir K., Shameer, Khader, Arvizo, Rochelle R., Kudgus, Rachel A., Dwivedi, Shailendra Kumar Dhar, Hossen, Md. Nazir, Gillies, Elizabeth M., Robertson, J. David, Dudley, Joel T., Urrutia, Raul A., Postier, Russell G., Bhattacharya, Resham, Mukherjee, Priyabrata
Foilsithe in ACS Nano (2016)

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approac...

le DuBois, Steven G., Marachelian, Araz, Fox, Elizabeth, Kudgus, Rachel A., Reid, Joel M., Groshen, Susan, Malvar, Jemily, Bagatell, Rochelle, Wagner, Lars, Maris, John M., Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Czarnecki, Scarlett, Tsao-Wei, Denice, Matthay, Katherine K., Mosse, Yael P.
Foilsithe in J Clin Oncol (2016)

Phase 2 Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

le DuBois, Steven G., Mosse, Yael P., Fox, Elizabeth, Kudgus, Rachel A., Reid, Joel M., McGovern, Renee, Groshen, Susan, Bagatell, Rochelle, Maris, John M., Twist, Clare J., Goldsmith, Kelly, Granger, M. Meaghan, Weiss, Brian, Park, Julie R., Macy, Margaret E., Cohn, Susan L., Yanik, Greg, Wagner, Lars, Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Boucher, Najee, Czarnecki, Scarlett, Luo, Chunqiao, Tsao-Wei, Denice D., Matthay, Katherine K., Marachelian, Araz
Foilsithe in Clin Cancer Res (2018)

Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice

le Stojakovic, Andrea, Trushin, Sergey, Sheu, Anthony, Khalili, Layla, Chang, Su-Youne, Li, Xing, Christensen, Trace, Salisbury, Jeffrey L., Geroux, Rachel E., Gateno, Benjamin, Flannery, Padraig J., Dehankar, Mrunal, Funk, Cory C., Wilkins, Jordan, Stepanova, Anna, O’Hagan, Tara, Galkin, Alexander, Nesbitt, Jarred, Zhu, Xiujuan, Tripathi, Utkarsh, Macura, Slobodan, Tchkonia, Tamar, Pirtskhalava, Tamar, Kirkland, James L., Kudgus, Rachel A., Schoon, Renee A., Reid, Joel M., Yamazaki, Yu, Kanekiyo, Takahisa, Zhang, Song, Nemutlu, Emirhan, Dzeja, Petras, Jaspersen, Adam, Kwon, Ye In Christopher, Lee, Michael K., Trushina, Eugenia
Foilsithe in Commun Biol (2021)